Sue Marshall blogs about diabetes for Desang

Bayer Diabetes Care – new website

February 15, 2010
Leave a Comment

The new-look Bayer Diabetes Care website gives access to lots of useful information and tools to help you manage your diabetes, such as ‘Live your life’, a new section packed full of information and tools to help you manage your diabetes day in, day out.

There’s also ‘Connect with my community’ where you can read inspirational stories about real people living with diabetes and add your own story if you’d like to share it.

Some of the most popular features from our original site are retained, such as the ability to personalise your meter with free funky stickers and, if you use Contour or Contour Link, a free coloured wallet. You can also order support items such as record diaries and batteries, also for free.

If you are already a registered user you can login using the same username and password as before.

Bayer Diabetes Care – Home.


Victoza approved for US market

February 3, 2010
Leave a Comment

Novo Nordisk has announced that the US Food and Drug Administration (FDA) has granted marketing authorisation for Victoza® for the treatment of type 2 diabetes in adults.1

Victoza is the brand name approved in the US and Europe for liraglutide, the first once-daily human Glucagon-like peptide-1 (GLP-1) analogue developed for the treatment of type 2 diabetes. In the US, Victoza® is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. This provides for Victoza® to be used in monotherapy, (although not as first line therapy) and in combination with commonly prescribed oral medications for diabetes.

In Europe, EU Commission granted marketing authorisation for liraglutide on 30 June 2009, for all 27 European Union member states.2 It has been on the market in the UK since 7 July 2009. According to the EU authorisation, liraglutide is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with:

– Metformin or a sulphonylurea in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin or sulphonylurea, and

– Metformin and a sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycaemic control despite dual therapy.

“The US approval of liraglutide represents an important milestone for Novo Nordisk that follows the recent approval in Japan and the ongoing successful launch in Europe”, says Lars Rebien Sørensen, president and CEO. “We are convinced that liraglutide will prove to be a valuable treatment option for people with type 2 diabetes in the US.”

Novo Nordisk expects to introduce Victoza in the US market within weeks.


‘Fat Hormone’ May Hold Key to Reversing Type 2 Diabetes | Diabetes News Hound

January 18, 2010
Leave a Comment

Leptin, commonly referred to as the fat hormone, may hold the key to reversing Type 2 diabetes, according to a recent article on WebMD.

New research suggests that just a small amount of the hormone can control a gene in the liver that has shown to help diabetic mice. However, unlike other studies, which conclude that this hormone may help diabetics by promoting weight loss, the researchers in the current study suggests that the amount of the hormone used in this study is too small to promote weight loss. They say these results show that the benefits of this hormone on diabetes and on weight loss are independent of each other.

via ‘Fat Hormone’ May Hold Key to Reversing Type 2 Diabetes | Diabetes News Hound.

SpringerLink – Journal Article

January 15, 2010
Leave a Comment

A report in Diabetologia asserts stress leads to inflammation leads to Type 2 diabetes:

“The recent major increase in the global incidence of type 2 diabetes suggests that most cases of this disease are caused by changes in environment and lifestyle. All major risk factors for type 2 diabetes (overnutrition, low dietary fibre, sedentary lifestyle, sleep deprivation and depression) have been found to induce local or systemic low-grade inflammation that is usually transient or milder in individuals not at risk for type 2 diabetes. By contrast, inflammatory responses to lifestyle factors are more pronounced and prolonged in individuals at risk of type 2 diabetes and appear to occur also in the pancreatic islets. Chronic low-grade inflammation will eventually lead to overt diabetes if counter-regulatory circuits to inflammation and metabolic stress are compromised because of a genetic and/or epigenetic predisposition. Hence, it is not the lifestyle change per se but a deficient counter-regulatory response in predisposed individuals which is crucial to disease pathogenesis. Novel approaches of intervention may target these deficient defence mechanisms.”

via SpringerLink – Journal Article.

Six New Diabetes Technologies Currently Under Development | Diabetes News Hound

January 6, 2010
Leave a Comment

Diabetes management has benefitted tremendously in the past few decades by the development of new medicines and technologies. A look here at six more that are on the way.

via Six New Diabetes Technologies Currently Under Development | Diabetes News Hound.

Stunning stats on global ‘epidemic’ of diabetes from International Diabetes Foundation (IDF)

January 5, 2010
Leave a Comment

MONTREAL, Canada. The International Diabetes Federation (IDF) released new data today showing that a staggering 285 million people worldwide have diabetes. The latest figures from the IDF Diabetes Atlas indicate that people in low and middle-income countries (LMCs) are bearing the brunt of the epidemic, and that the disease is affecting far more people of working age than previously believed.

In 1985, the best data available suggested that 30 million people had diabetes worldwide. Fast-forward 15 years and the numbers were revised to just over 150 million. Today, less than 10 years on, the new figures – launched at the 20th World Diabetes Congress in Montreal, Canada – put the number closer to 300 million, with more than half aged between 20 and 60. IDF predicts that, if the current rate of growth continues unchecked, the total number will exceed 435 million in 2030 – many more people than the current population of North America.

Professor Jean Claude Mbanya, President of the International Diabetes Federation, voiced concern: “The data from the latest edition of the IDF Diabetes Atlas show that the epidemic is out of control. We are losing ground in the struggle to contain diabetes. No country is immune and no country is fully equipped to repel this common enemy.”

Type 1 diabetes cannot be prevented. It is an autoimmune disease in which the body destroys its own insulin-producing cells. People with type 1 diabetes require daily injections of insulin to survive. The majority of all diabetes is type 2 diabetes (85%-95%), which in many cases can be prevented. People with type 2 diabetes cannot use the insulin they produce effectively, but can often manage their condition through exercise and diet, although many go on to require medication, including insulin, to properly control blood glucose levels. It is estimated 60% or more of type 2 diabetes could be prevented.

Both type 1 and type 2 diabetes represent a serious health threat. Diabetes claims four million lives every year and is a leading cause of blindness, kidney failure, heart attack, stroke and amputation

Eamonn Holmes and Ruth Langsford Get Serious about diabetes – Diabetes UK

December 10, 2009
Leave a Comment

This Morning presenters Eamonn Holmes and partner Ruth Langsford have shown their commitment to Get Serious about diabetes by signing up to the campaign.

By giving us their name and email address they have joined more than 3,000 other Get Serious supporters across the UK who want to see diabetes be made a top priority.

via Eamonn Holmes and Ruth Langsford Get Serious about diabetes – Diabetes UK.

Next Generation Blood Glucose Meters – Diabetes Health

November 6, 2009
Leave a Comment

Another great little leader from Diabetes Health — pulse oximeters may be the next innovation for blood testing, and is non-invasive, so no more finger pricking. Phew.

Next Generation Blood Glucose Meters – Diabetes Health.

NHS Partnerships | Supporting young diabetes patients by podcast

November 5, 2009
1 Comment

Wild! The NHS getting into podcasts in this case for over 14-year-olds with Type 1 diabetes. Advocated by Sir Steve Redgrave who supports the project saying, ‘diabetes must live with you, not you live with diabetes.’

NHS Partnerships | Supporting young diabetes patients by podcast.

The Big Blue Test on World Diabetes Day – TuDiabetes – A Community for People Touched by Diabetes

November 4, 2009
Leave a Comment

The Big Blue Test on World Diabetes Day – TuDiabetes – A Community for People Touched by Diabetes.

November 14 is World Diabetes Day. On that day, at 14:00 hours (2 pm, local time), thousands of people with diabetes will test their blood sugar, do 14 minutes of exercise, test again and share their results online.

The event is called The Big Blue Test because the blue circle is the international symbol for diabetes. The idea of a shared “blood sugar test-in” started with an activity organized in July 2009 by, a community for people touched by diabetes. More than a thousand people participated then. Now, we seek to reach thousands of people with diabetes through eight diabetes social networks* and Twitter. The activity incorporates 14 minutes of physical activity to reinforce the importance of exercise.

“People with diabetes have to test their blood sugar routinely. It can be a very lonely activity.” said Manny Hernandez, co-founder of TuDiabetes and a person with diabetes himself. “We want people to take The Big Blue Test, to shed light on this chronic condition and the importance of exercise on World Diabetes Day.”

Currently, more than 250 million people have diabetes worldwide. Millions more have diabetes but do not know it yet. People with diabetes need to test their blood sugar levels several times a day and exercise regularly.

Participating in this event to raise diabetes awareness on November 14 is easy:

1. Test your blood sugar.

2. Run, jog, walk the dog or do anything you’d normally do as part of your exercise routine for 14 minutes.

3. Test your blood sugar again.

4. Go to (or your preferred diabetes social network*) and post your readings and what physical activity you did. If you have a camera, you can also add a photo of your reading(s) or you exercising.

5. If you have a Twitter account, you can also post your readings on Twitter (use the #bigbluetest hashtag) and link back to

“We hope to see most readings posted at 14 hours (2 pm) local time, on November 14. If you are early or late, it’s OK,” said Hernandez. “What matters most is that you test your blood sugar often and that you exercise regularly. If you don’t have diabetes, you can take The Big Blue Test. Either way, tell others to test, exercise and share on Nov. 14.”

I’m going to do it & my exercise will be a walk along Brighton seafront, come rain, wind or sunshine. What a great way to unite a global community. Well done Manny.

Next Page »

    Search Sue Marshall’s blog

    Desang Diabetes Directory

    See our directory of diabetes management kit -- blood test machines, insulin delivery devices, finger-prickers.

    Sue Marshall picture

    Sue Marshall